Mucus Relief Tablet
Product Images NDC 36800-932

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Mucus Relief (NDC 36800-932). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Top Care (topco Associates Llc), these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Guaifenesin 1200 mg (Mucus Relief 1200 mg Extended Release Caplets 1)

Guaifenesin 1200 mg (Mucus Relief 1200 mg Extended Release Caplets 1)
This is a drug fact sheet for an extended-release tablet containing 1200 mg of Guaifenesin, which helps to loosen phlegm/mucus and thin bronchial secretions. It is designed for use by adults and children over age 12, with up to 2 tablets taken every 12 hours. This product is not intended for use by children under age 12. Users are advised to seek medical advice before use if they have certain conditions such as persistent or chronic cough, asthma, chronic bronchitis, or emphysema. They are also advised to stop use and seek medical assistance if their cough persists for more than 7 days or is accompanied by fever, rash, or headache, as this could be a sign of a serious issue. Pregnant women and people who are breastfeeding are advised to consult a health professional before use. Inactive ingredients include hypromellose, magnesium stearate, and microcrystalline cellulose. This product is distributed by Topco Associates LLC in Elk Grove Village, IL.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.